DCGI approves Keytruda for treatment of cervical cancer: MSD

Jan 24, 2023

According to MSD, Keytruda is the first cancer immunotherapy to be approved in India for the treatment of cervical cancer and the first immunotherapy...

NeoImmuneTech obtains approval for phase 2 trial of brain tumor treatment from US FDA

May 12, 2022

Seoul [South Korea], May 12 (ANI/Global Economic): NeoImmuneTech said on the 11th that it has obtained the approval for a phase 2 clinical trial...